Skip to content

A Study of a Low-Carbohydrate Diet to Improve Maternal Health After Childbirth

A Randomized Trial of a Low Carbohydrate Diet Versus the Current Recommended Dietary Guidelines to Improve Health Outcomes in Obese Postpartum Women

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04045353
Acronym
SLIM
Enrollment
11
Registered
2019-08-05
Start date
2019-12-20
Completion date
2022-07-01
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Sensitivity, Obesity, Postpartum Weight Retention

Keywords

Low carbohydrate diet

Brief summary

The study is evaluating the effects of a standard diet to a low carbohydrate diet in obese women after having a baby. The purpose of the study is to determine if a low carbohydrate diet is associated with improvement in insulin sensitivity in postpartum women.

Interventions

BEHAVIORALLow carbohydrate diet education

A 200 page informational document that connects with an online application will be provided to subjects.

BEHAVIORALLow carbohydrate diet education with behavioral component

A 12 week course taught be a certified instructor will teach subjects about a low carbohydrate document. Subjects will also be given a 200 page informational document that connects with an online application.

Sponsors

The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Delivery at University of Texas Medical Branch * Body max index greater than or equal to 30 kilograms/meters squared at the final prenatal visit prior to delivery. * Singleton gestation. * Accessibility to the internet. * Basic understanding and comprehension of the English language to be assessed by study personnel at the time of recruitment.

Exclusion criteria

* Diabetes mellitus on medication. * Serious medical condition, such as heart failure, kidney failure, or severe asthma, as determined by the principle investigator. * Planned pregnancy during study period. * Enrolled in another trial that may affect outcome. * Subject unlikely to be followed up after delivery.

Design outcomes

Primary

MeasureTime frameDescription
Change in insulin sensitivity as measured by homeostatic model assessment of insulin sensitivity.Baseline, 3 monthsHomeostatic model assessment for measurement of insulin sensitivity will be computed with fasting insulin and glucose levels (fasting for at least 8 hours) with the following calculation: (glucose x insulin/22.5). This calculation is measured in molar units (mmol/L).

Secondary

MeasureTime frameDescription
Change in insulin sensitivity as measured by homeostatic model assessment of insulin sensitivity.Baseline, 6 monthsHomeostatic model assessment for measurement of insulin sensitivity will be computed with fasting insulin and glucose levels (fasting for at least 8 hours) with the following calculation: (glucose x insulin/22.5). This calculation is measured in molar units (mmol/L).
Change in weight measured in pounds.Baseline, 3 monthsThe subject will be weighed at baseline and at 3 months.The weight will be calculated in pounds.
Development of diabetes postpartum as measured by 2 hour glucose tolerance test.3 monthsAs part of routine postpartum care, women at risk for diabetes have a glucose tolerance test performed within 3 months postpartum.
Change in blood pressure as measured by blood pressure cuff in mmHg.Baseline, 3 monthsThe subject will have blood pressure checked at baseline and at 3 months. Blood pressure will be calculated in mmHg.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026